Kellye Mixson
Psychiatric/Mental Health · Austin, TXNPI 1255965273
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 364 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,039 and has fallen 97.9% since, to $43 in 2024. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 364 payments — averaging $14.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$880
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$848
- Otsuka America Pharmaceutical, Inc.$677
- Alkermes, Inc.$536
- Ironshore Pharmaceuticals Inc.$372
- Sunovion Pharmaceuticals Inc.$364
- plus $2K from 13 others
What the payments were for
- Food & beverage$5,323100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 73 | $880 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 56 | $848 |
| Otsuka America Pharmaceutical, Inc. | 37 | $677 |
| Alkermes, Inc. | 38 | $536 |
| Ironshore Pharmaceuticals Inc. | 23 | $372 |
| Sunovion Pharmaceuticals Inc. | 32 | $364 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $304 |
| Lundbeck LLC | 17 | $295 |
| Corium, LLC | 17 | $212 |
| Neos Therapeutics, LP | 13 | $189 |
| Tris Pharma Inc | 15 | $189 |
| Teva Pharmaceuticals USA, Inc. | 9 | $179 |
| Neurocrine Biosciences, Inc. | 4 | $79 |
| Supernus Pharmaceuticals, Inc. | 4 | $64 |
| Eisai Inc. | 3 | $51 |
| Johnson & Johnson | 3 | $37 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Noven Therapeutics, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$124
How this compares
$5,323 in reported general payments places this provider in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in Austin
- Jaime Nelson DensonAustin$88K
- Camille WatsonAustin$34K
- Suzanne GranthamAustin$31K
- Lin CaiAustin$16K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.